The capping enzyme plays a pivotal role in coupling transcription and mRNA processing. It binds selectively to the elongating form of RNA polymerase II, where the largest subunit contains a phosphorylated C-terminal domain . This interaction ensures that capping occurs co-transcriptionally, which is vital for the proper processing and function of mRNA .
The human RNGTT gene was identified by screening a HeLa cell library using a mouse cDNA probe. The predicted human and mouse proteins share 95% identity, indicating a high degree of conservation across species . The enzyme is expressed in all human tissues tested, highlighting its fundamental role in cellular processes .
Recombinant HCE1 protein has been shown to display both RNA 5’-triphosphatase and guanylyltransferase activities. It can form a cap structure at the 5’-triphosphate end of RNA, which is essential for mRNA stability and function . The recombinant protein has been used in various research applications to study mRNA capping and its implications in gene expression regulation .
Mutations or dysregulation of the RNGTT gene can have significant implications for human health. For example, RNGTT is associated with diseases such as Subserous Uterine Fibroid and Machado-Joseph Disease . Understanding the function and regulation of this enzyme can provide insights into the molecular mechanisms underlying these conditions and potentially lead to therapeutic interventions .